"The Report Sepsis -
Pipeline Review, H1 2016 provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz"
Global Markets Directs, Sepsis -
Pipeline Review, H1 2016, provides an overview of the Sepsis pipeline
landscape.
The report provides comprehensive
information on the therapeutics under development for Sepsis,
complete with analysis by stage of development, drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type. The report also covers the descriptive pharmacological action
of the therapeutics, its complete research and development history
and latest news and press releases. Additionally, the report provides
an overview of key players involved in therapeutic development for
Sepsis and features dormant and discontinued projects.
Global Markets Directs report
features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Drug profiles featured in the report undergoes
periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
The report helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.
View Report @
http://www.marketresearchreports.biz/analysis/677065
Scope
- The report provides a snapshot
of the global therapeutic landscape of Sepsis
- The report reviews pipeline
therapeutics for Sepsis by companies and universities/research
institutes based on information derived from company and
industry-specific sources
- The report covers pipeline
products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- The report features descriptive
drug profiles for the pipeline products which includes, product
description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key players
involved Sepsis therapeutics and enlists all their major and minor
projects
- The report assesses Sepsis
therapeutics based on drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type
- The report summarizes all the
dormant and discontinued pipeline projects
- The report reviews latest news
related to pipeline therapeutics for Sepsis
Get Sample Copy Of This Report
@
Reasons to buy
- Gain strategically significant
competitor information, analysis, and insights to formulate effective
R&D strategies
- Identify emerging players with
potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Identify and understand
important and diverse types of therapeutics under development for
Sepsis
- Identify potential new clients
or partners in the target demographic
- Develop strategic initiatives by
understanding the focus areas of leading companies
- Plan mergers and acquisitions
effectively by identifying key players and its most promising
pipeline therapeutics
- Devise corrective measures for
pipeline projects by understanding Sepsis pipeline depth and focus of
Indication therapeutics
- Develop and design in-licensing
and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential
and scope
- Modify the therapeutic portfolio
by identifying discontinued projects and understanding the factors
that drove them from pipeline
Table
Of Contents :
Table
of Contents 2
List
of Tables 7
List
of Figures 9
Introduction
10
Global
Markets Direct Report Coverage 10
Sepsis
Overview 11
Therapeutics
Development 12
Pipeline
Products for Sepsis - Overview 12
Pipeline
Products for Sepsis - Comparative Analysis 13
Sepsis
- Therapeutics under Development by Companies 14
Sepsis
- Therapeutics under Investigation by Universities/Institutes 20
Sepsis
- Pipeline Products Glance 21
Late
Stage Products 21
Clinical
Stage Products 22
Early
Stage Products 23
Sepsis
- Products under Development by Companies 24
Sepsis
- Products under Investigation by Universities/Institutes 29
Sepsis
- Companies Involved in Therapeutics Development 31
Adrenomed
AG 31
Altor
BioScience Corporation 32
Am-Pharma
B.V. 33
Arch
Biopartners, Inc. 34
Aridis
Pharmaceuticals LLC 35
Asahi
Kasei Pharma Corp. 36
Baxalta
Incorporated 37
Biomedica
Management Corporation 38
Boehringer
Ingelheim GmbH 39
Bristol-Myers
Squibb Company 40
Cell2B
S.A. 41
Chiesi
Farmaceutici SpA 42
Chiome
Bioscience, Inc. 43
Cilian
AG 44
Cognosci,
Inc. 45
Diomune
S.L 46
Endacea,
Inc. 47
Evec,
Inc. 48
Ferring
International Center S.A. 49
Huons
Co., Ltd. 50
Immune
Response BioPharma, Inc. 51
Immunethep,
SA 52
ImmunNovative
Developments SL 53
InflaRx
GmbH 54
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment